Executive Summary

Oct 2019
PROSPECTS
Prevalence of dermatological conditions remains high due to low hygiene standards

Living conditions in Egypt’s major cities are still some way behind those of developed countries, with life in Cairo in particular presenting challenges for many. This continues to support strong growth for dermatologicals, principally because high levels of population density and low hygiene standards, including in public areas, motivates people to overcompensate when faced with skin issues.

High birth rate continues to support strong growth in nappy (diaper) rash treatments

Egypt’s birth rate remains very high, standing at 2.6% in 2018.

Unit price stability returns to the category, supporting higher demand

Unit prices saw greater stability in dermatologicals in 2019 after previous years of the review period saw dramatic unit price increases due to currency devaluation. This was the first year for decades that strong unit price growth was not seen in the category and the Ministry of Health has stated that no further price increases will be implemented in the category over the short to medium term.

COMPETITIVE LANDSCAPE
GSK Consumer Healthcare leads sales with a wide portfolio of trusted brands

2019 saw GSK Consumer Healthcare hold first position in dermatologicals as consumers continue to place high levels of trust in its various brands. GSK Consumer Healthcare is the player behind the Dermovate, Lamisil, Zovirax and Fenistil brands, all of which have a strong presence in chemists/pharmacies throughout the country.

Local brands benefit from low prices and less stringent consumer expectations

In general, imported dermatologicals brands struggle to compete with their local rivals on price, a situation which has been brought into sharp focus by the devaluation of the Egyptian pound in 2017. Exacerbating the situation is the fact that many local consumers perceive there to be very few differences between imported and local brands in basic essential categories such as topical germicidals/antiseptics, which remains the dominant category in dermatologicals in Egypt.

No new launches seen in the category due to stringent regulations and low margins

Dermatologicals did not witness any new launches during 2019 as the majority of players in the category remained in survival mode and thus focused on maximising sales of their current brands rather than taking the risk on the launch of new products. The current leading players in the category are also still recovering from previous losses incurred due to higher unit price increases and the inflexibility of government price controls.

Want to find out more about this report?
Request more information
Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Your Recently Viewed Reports

Dermatologicals in Egypt

Samples (FAQs about samples):

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Medicated Skin Care industry in Egypt with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Medicated Skin Care industry in Egypt, our research will save you time and money while empowering you to make informed, profitable decisions.

The Medicated Skin Care in Egypt market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Medicated Skin Care in Egypt?
  • What are the major brands in Egypt?
  • What are the most popular formats for acne treatments?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Dermatologicals in Egypt - Category analysis

HEADLINES

PROSPECTS

Prevalence of dermatological conditions remains high due to low hygiene standards
High birth rate continues to support strong growth in nappy (diaper) rash treatments
Unit price stability returns to the category, supporting higher demand

COMPETITIVE LANDSCAPE

GSK Consumer Healthcare leads sales with a wide portfolio of trusted brands
Local brands benefit from low prices and less stringent consumer expectations
No new launches seen in the category due to stringent regulations and low margins

CATEGORY DATA

Table 1 Sales of Dermatologicals by Category: Value 2014-2019
Table 2 Sales of Dermatologicals by Category: % Value Growth 2014-2019
Table 3 NBO Company Shares of Dermatologicals: % Value 2015-2019
Table 4 LBN Brand Shares of Dermatologicals: % Value 2016-2019
Table 5 LBN Brand Shares of Hair Loss Treatments: % Value 2016-2019
Table 6 Forecast Sales of Dermatologicals by Category: Value 2019-2024
Table 7 Forecast Sales of Dermatologicals by Category: % Value Growth 2019-2024

Consumer Health in Egypt - Industry Overview

EXECUTIVE SUMMARY

Demand continues to increase in consumer health despite high inflation
Strong self-medication culture support sales in all OTC categories
Stability in the competitive environment the result of regulatory burdens
Strict regulations limit product distribution to chemists/pharmacies
Further sales growth anticipated over the forecast period

MARKET INDICATORS

Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2014-2019
Table 9 Life Expectancy at Birth 2014-2019

MARKET DATA

Table 10 Sales of Consumer Health by Category: Value 2014-2019
Table 11 Sales of Consumer Health by Category: % Value Growth 2014-2019
Table 12 NBO Company Shares of Consumer Health: % Value 2015-2019
Table 13 LBN Brand Shares of Consumer Health: % Value 2016-2019
Table 14 Distribution of Consumer Health by Format: % Value 2014-2019
Table 15 Distribution of Consumer Health by Format and Category: % Value 2019
Table 16 Forecast Sales of Consumer Health by Category: Value 2019-2024
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2019-2024

APPENDIX

OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches

DEFINITIONS

SOURCES

Summary 1 Research Sources